欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0419/002
药品名称
PERIOLIMEL N4E
活性成分
Glucose 0.0 00
剂型
Emulsion for infusion
上市许可持有人
BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Ireland (IE)
Cyprus (CY)
Germany (DE)
Olimel Peri 2,5% E Emulsion zur Infusion
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Austria (AT)
PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion
Italy (IT)
Greece (GR)
OLIMEL
Bulgaria (BG)
Malta (MT)
Norway (NO)
Poland (PL)
Olimel N5E
Finland (FI)
Sweden (SE)
许可日期
2009/10/23
最近更新日期
2025/01/06
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final PL
|
common_pl_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
Final SPC
|
common_spc_cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase